Sunday, March 15, 2026 6:59:31 PM
Jesster, I believe all the proof you need should come from Posner's taking a spoofing suit on contingency against the 7 largest MM's for NWBO. She's one of the top litigators in this field, if it goes to full discovery, and she can expose their action all the way to the present, I'm sure it will show just how hard they're working. I don't know that it will happen, they may settle sooner, or the court may limit how far they can look, but I believe that the more they see, the more they'll be permitted to see. Even if they're not permitted to go beyond what occurred at the time of the NYAS presentation, I believe the award will be substantial.
The point is, the 7 MM's can facilitate naked shorting by clients through derivatives that can't be seen. If those clients are smart they've been closing these positions while the stock's down, but I still believe a large naked position may exist. We should get a substantial squeeze on approval, how high we spike to may be caused by the squeeze, but will largely be dependent on how much media attention we get with the news of the approval.
I honestly don't understand derivatives and other maneuvers the MM's, hedge funds, etc. can facilitate. I wish investing was simply looking for companies that would succeed and investing in them, but investing has gone far beyond that. Hedge fund managers who made billions for their clients by bringing companies down have earned billions of dollars in bonuses themselves based on the money they've made for their clients. In 2008 they virtually brought down the economy and took some of the biggest companies into bankruptcy, the likes of Lehman Bros, WaMu, etc. are no longer with us because of how things were done back then, and most of it's still legal today.
Frankly, if we do hit peaks at $10 or more, I'd be willing to bet that shorts who may have big losses on the approval announcement are right back in their short positions at least for the retrenching that undoubtably will occur after such a peak. I don't know if they'll recover all their losses, but recovering some of it is practically certain. I believe if they're smart they get out on retrenching as more news can bring new highs.
Gary
The point is, the 7 MM's can facilitate naked shorting by clients through derivatives that can't be seen. If those clients are smart they've been closing these positions while the stock's down, but I still believe a large naked position may exist. We should get a substantial squeeze on approval, how high we spike to may be caused by the squeeze, but will largely be dependent on how much media attention we get with the news of the approval.
I honestly don't understand derivatives and other maneuvers the MM's, hedge funds, etc. can facilitate. I wish investing was simply looking for companies that would succeed and investing in them, but investing has gone far beyond that. Hedge fund managers who made billions for their clients by bringing companies down have earned billions of dollars in bonuses themselves based on the money they've made for their clients. In 2008 they virtually brought down the economy and took some of the biggest companies into bankruptcy, the likes of Lehman Bros, WaMu, etc. are no longer with us because of how things were done back then, and most of it's still legal today.
Frankly, if we do hit peaks at $10 or more, I'd be willing to bet that shorts who may have big losses on the approval announcement are right back in their short positions at least for the retrenching that undoubtably will occur after such a peak. I don't know if they'll recover all their losses, but recovering some of it is practically certain. I believe if they're smart they get out on retrenching as more news can bring new highs.
Gary
Bullish
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
